STUDY ON SAFETY AND EFFECTIVENESS OF ORAL TOFACITINIB IN PATIENTS WITH REFRACTORY MODERATE TO SEVERE ATOPIC DERMATITIS. (2018). International Research Journal of Pharmacy, 9(8), 125-128. https://doi.org/10.56802/gzfvmr94